साउथ Africa: Saving lives is not always easy

By, IRIN PlusNews, May 21, 2008

To be a nurse at Sizwe Hospital, a special facility for treating patients infected with drug-resistant strains of tuberculosis (TB), requires a thick skin and a forgiving nature.

Cecelia Mngomezulu, the hospital's head matron, has been verbally abused, spat on, assaulted and held hostage in the two years that she has worked there.

"I sometimes get angry at them, but something tells you that at the end of the day this person is projecting, and then you put yourself in his shoes and you find yourself coming back," she told IRIN/PlusNews.

The hospital, housed in a sprawling, colonial-era complex in a quiet Johannesburg suburb, is the only referral centre in Gauteng Province for treating multidrug-resistant (MDR) TB, which is resistant to first-line TB medication and can take up to two years to treat. Patients with extremely drug-resistant (XDR) TB, which is resistant to most second-line drugs and can take even longer to treat, are also referred here.

Drug-resistant TB poses an especially serious public health threat in a country like South Africa, where nearly one in five people are infected with HIV: those living with HIV are 50 times more likely to get TB.

Isolation policy

The policy of South Africa's health department is to treat all MDR-TB patients at special isolation facilities like Sizwe until they are no longer infectious. The minimum period patients have to spend away from their families, their jobs and their homes is six months, but some have been at Sizwe for as long as two years. Family members are allowed to visit, and there are games, TV rooms and other activities to stave off boredom and depression, but frustrations are still often vented on the staff.

"They try to make you feel guilty, like you're holding them hostage against their will," said Mngomezulu. "They'll say, 'You can go home and see your children, what about me? Don't you have a feeling?' Yet you're thinking of their actual families, that they'll be infected if you discharge them."

They try to make you feel guilty, like you're holding them hostage against their will
The degree to which facilities like Sizwe hold patients against their will is something of a grey area. According to the hospital's CEO, Rianna Louw, patients are counselled at their local clinic and sign a consent form before being admitted.

"There are problems in terms of that, because some of the patients will say they didn't get proper information, that they weren't told they were going to be admitted for a long time," Louw told IRIN/PlusNews. "It's voluntary in the sense that we're not bringing them in with police, but in terms of the policy, all MDR patients should be admitted - it's an infectious disease."

Last week, several patients at Sizwe had to be temporarily transferred to a hospital in Pretoria after becoming aggressive. A local newspaper, The Star, reported the disgruntled patients as saying that the hospital "had broken one promise too many".

Louw attributes such incidents to patients having unrealistic expectations about the length of their stay at the hospital. "I think there is this expectation that they will only be here for six months, but that's really only a minimum. The policy is that you discharge them when they're culture-negative," meaning that they are no longer infectious.

Dr Xavier Padanilam, the hospital's chief medical officer, explained that a patient must have two culture-negative test results before they are deemed non-infectious and can be discharged and allowed to complete their treatment as out-patients. A culture test takes up to eight weeks to produce results, so a patient could be non-infectious for up to four months before being allowed to go home.

Recruitment challenge

Mngomezulu's hostage experience occurred earlier this year. "They had sticks and iron bars and bricks they picked up somewhere, and they said, 'You're not going home'. They held me from four [p.m.] until the police came at seven [p.m.]," she recalled. "Amazingly, I wasn't afraid. They try to intimidate a lot."

Most of the staff have experienced verbal or even physical abuse from patients, said Louw. "Patients most of the time respect professionals, but it sometimes happens in this hospital that that respect disappears because of the anger and frustration," she said, adding that such feelings often stem from not being able to support their families at home.

The hospital has a full staff complement of seven doctors, but about 20 percent of professional nursing posts remain vacant, despite the special allowance the provincial health department recently started offering as an incentive to work there.

"It's a very big challenge to recruit," said Mngomezulu. "Knowing it's an MDR hospital, there's that fear of the unknown. Yet because we're in here we don't have a problem; we know what we're dealing with."

The staff all wear protective masks and have access to an employee wellness clinic that is open daily. "In terms of education to staff, they know if they're HIV positive there's a higher risk [of contracting TB]," said Louw. "Because of confidentiality, we can't exclude people living with HIV from working here, but we encourage them to test and then declare to us."

Nurses occasionally contract TB despite these precautions, but none have had MDR-TB.

Mngomezulu had TB before she came to Sizwe, but was not deterred by the risk of contracting it again. "Coming here was a way of being a role model, to show you can get cured if you comply with your treatment," she said. "Because I suffered, I know how it feels to have those night sweats and chest pains, and to have to remember to swallow those tablets."

ks/he

Source: http://www.plusnews.org/Report.aspx?ReportId=78313

Drug resistant TB on rise in UK

By, NHS Choices, May 2, 2008

“Cases of drug-resistant tuberculosis are on the rise”, the Daily Mail reported today. The Guardian also says that a study published in the British Medical Journal has found that cases of drug resistant TB in the UK nearly doubled between 1998 and 2005. They report that rising immigration and inadequate measures to control outbreaks “among prisoners and drug users” could be to blame. The Daily Mail also says the increase is thought to be linked to immigrants, particularly from sub-Saharan Africa and the Indian subcontinent, contracting drug-resistant TB abroad before moving to Britain.

Cases of TB have been occurring with increasing frequency over recent decades. As with other bacterial infections, drug resistant forms of TB will develop over time as bacteria adapt to overcome the actions of commonly used antibiotics. The increase in resistance to one first-line drug treatment for TB (isoniazid) has been small, but significant, since 1998. There are still treatment options for which resistance has not increased.

As the researchers behind this study point out, this highlights the need for early diagnosis of suspected cases, the rapid testing for the types of antibiotic to which the particular strain of TB is susceptible and ensuring that patients complete their course of treatment.

Where did the story come from?

Michelle E. Kruijshaar and colleagues from the Health Protection Agency and Queen Mary’s School of Medicine and Dentistry, London, Newcastle General Hospital, the Heart of England NHS Foundation Trust, Birmingham, and the University of East Anglia, carried out the research. The researchers received no funding for this study. The study was published in the peer-reviewed medical journal: British Medical Journal.

What kind of scientific study was this?

In this time-trend study, the researchers investigated trends in the UK for antibiotic resistance to tuberculosis (TB) between 1998 and 2005. The study also investigated possible causes for any changes in resistance.

The researchers wanted to include cases of TB that were reported between 1998 and 2005 and the antibiotics they had proved susceptible to. In order to do this, they combined data from two databases, the Mycobacterial Surveillance Network (MycobNet), which collects information about the drug susceptibility of circulating strains of TB, and the national enhanced tuberculosis surveillance database, which provided clinical information on the cases.

The cases in the databases were either confirmed by a laboratory culture or by a doctor’s diagnosis and decision to treat as TB based on clinical and radiological findings (non-culture confirmation). For this analysis, the researchers only included those cases confirmed by a culture.

The researchers examined trends in the resistance of TB to antituberculous drugs over the eight-year period. They saw how these were affected by individual variables such as age, sex, ethnicity, place of birth, region of habitation in the UK, previous diagnoses and site of disease (e.g. TB just affecting the lungs or with involvement of other parts of the body).

Multidrug resistance was defined as a case of TB that was resistant to two of the most commonly used drugs (isoniazid and rifampicin).

What were the results of the study?

Between 1998 and 2005, there were a total of 28,620 cases of TB in the UK confirmed by bacterial culture. The average age of TB patients in this period was 35 and 57% were male. Forty two per cent of the cases occurred in London and 69% of the patients had been born outside of the UK and of those, the average time that they had been in the UK before diagnosis was four years. There were 25,117 identified cases not confirmed by culture.

Results of drug susceptibility testing were available for nearly 100% of the culture-confirmed cases and this showed that the proportion of cases resistant to first line drugs rose from 5.6% in 1998 to 7.5% in 2005. Looking at the individual antibiotics separately, there were rises in resistance to isoniazid (5.0 to 6.9%) and rifampicin (1.0 to 1.2%), but not for two other drugs (ethambutol and pyrazinamide).

When the researchers looked at factors associated with the trends, they found there was a significant increase in isoniazid resistance within London over time. This was of borderline statistical significance (OR 1.04, 95% CI 1.00 to 1.07). There was no increase in isoniazid resistance over time outside of London. These measures were adjusted for ethnicity, place of birth and age. There were no significant increases in rifampicin or multidrug resistance when adjusted for other variables.

Those younger and born outside of the UK had a higher risk of drug resistance outside of London, but being born outside of the UK was linked with lower risk of isoniazid resistance within London. Those with a previous diagnosis were significantly more likely to be resistant to isoniazid. There were differences in risk of isoniazid resistance both within and outside of London between ethnic groups.

Resistance to other second and third line drug options was found to be low.

What interpretations did the researchers draw from these results?

The authors conclude that the proportion of cases of TB that were resistant to isoniazid increased from 1998 to 2005 and that this ‘reflects the increasing proportion of patients with tuberculosis who are not born in the UK and who are from certain ethnic minority groups, as well as inadequate control of transmission in London’.

They say this highlights the need for completing the recommended drug courses and instituting measures to control outbreaks in London.

What does the NHS Knowledge Service make of this study?

Cases of tuberculosis have been occurring with increasing frequency over recent decades and a higher proportion of cases occur in those who were born outside of the UK. However, as the authors say, it is “failures in management of patients in the UK [that] are contributing to the occurrence of multidrug resistance”.

As with other bacterial infections, the development of drug resistant forms of TB over time will invariably happen as antibiotics are used more regularly and bacteria adapt to overcome their actions. London is a large city with a high population density and is therefore going to take a large burden of these cases.

The method of data collection does have some limitations as the researchers acknowledge. For example:

Drug-resistant TB may be particularly prevalent among people living in relative poverty, the homeless or illicit drug users with whom the surveillance databases may have failed to identify. This would mean that the prevalence of TB in urban areas such as London is even higher than that found by this study.
The data does not account for other diseases or conditions that TB patients may have that could affect drug resistance, e.g. HIV.
The researchers only included cases of TB that could be found in both databases. There could have been inaccuracies in the matching of the cases between the two databases.

Cases of TB that had not been confirmed by a bacterial culture were not included in analyses. As there were a large number of these (25,117 cases), the patterns in this group could have swayed the overall findings, i.e. if resistance had not increased or had even reduced over time in this group, the overall result is unlikely to be significant considering how borderline the results are in the culture-confirmed cases.

There was less information on the use of second and third line drugs. However, the finding that resistance was low when they were used, suggests that cases can still be managed effectively. Similarly with rifampicin (another first line option for TB in the UK), there was no increase in resistance over time. This study highlights the need for early diagnosis of suspected cases, rapid testing for the types of antibiotic to which the tuberculosis strain is susceptible, and the importance of ensuring that patients complete their treatment courses. Continued surveillance is important in order to try prevent drug resistance from developing into the future.

Source: http://www.nhs.uk/news/2008/05May/Pages/DrugresistantTBonriseinUK.aspx

TB Fatally Stalking Southeast Asia's HIV Patients

By, News Post India, April 12, 2008

India, Myanmar, Nepal and Thailand have some of the highest rates of tuberculosis (TB)-HIV co-infection in Southeast Asia, says a World Health Organisation (WHO) report.

The prevalence rate of TB among people living with HIV has been estimated as 5.2 percent in India, 7.1 percent in Myanmar, 3.1 percent in Nepal and 7.6 percent in Thailand, says the report on tuberculosis in the region.

Patients with their immune systems disabled by HIV/AIDS face a 30 times greater risk than others of contracting TB.

And for HIV/AIDS patients in India, that's bad news because the country has the highest incidence of TB in the world. India is home to over 3.4 million TB patients - about one-fifth of the global figure.

For the WHO, India is part of the Southeast Asia region along with Bhutan, Bangladesh, Indonesia, Myanmar, Thailand, the Maldives, Sri Lanka, Nepal, Timor-Leste and North Korea. The region has 25 percent of the world's population but accounts for more than one-third of the global burden of TB, the report said.

'TB is the single most life-threatening infection and the leading cause of mortality among people living with HIV infection in the region,' it added.

'The rapidly expanding HIV epidemic in the region is a growing concern. The HIV epidemic has reached a generalised stage in Thailand, Myanmar and in six states in India,' the report pointed out.

The six high-prevalence states in India are Andhra Pradesh, Karnataka, Manipur, Maharashtra, Nagaland and Tamil Nadu.

India has 2.5 million plus HIV patients.

The report said during 2006 in 14 states in India, 25,055 HIV infected TB suspects were referred to the Revised National TB Control Programme (RNTCP) services. Of these, 4,829 were diagnosed as HIV infected TB cases.

'The course of the TB/HIV epidemic in Southeast Asia will depend heavily on efforts to prevent and control both TB and HIV, and decisive steps must be taken now to combat the dual epidemics,' the WHO report said.

Of the 38.6 million people estimated to be living with HIV in the world at the end of 2005, more than four million are in Southeast Asia, said the recently released report on tuberculosis in the region.


Source: http://newspostindia.com/report-48024

TB still big public health problem

By, Charles Mpaka, The Daily Times, April 14, 2008

National Tuberculosis Control Programme (NTP) said last Friday that TB was still a big public health problem in Malawi inspite of successes the country has registered in the fight against the disease.

NTP said this in Blantyre at a briefing intended to enable the media come to grips with technical issues about TB.

NTP said from 2003, the number of TB cases from the districts has not gone up or down.

“This does not mean that TB has become a less problem,” said NTP Director Felix Salaniponi.

“It is still a big public health problem. It is killing people. Because of its chronic nature and the length of time it takes to cure it, time is being spent on caring for patients.”

Salaniponi reported that 75 people develop the disease everyday while 15 others die from TB every day.

“The major challenge is that we are not finding many cases that should have been coming to us. In that case, the TB situation will not go down because these cases we have not detected could be spreading the disease to others. This contributes to TB being an emergency case in Malawi,” Salaniponi said.

The World Health Organisation ranks Malawi as achieving a low detection rate of less than 50 percent, especially among the poor who are underserved and face problems such as geographical distance and high opportunity costs to access TB diagnostic and treatment.

Malawi recorded a 98 percent cure rate between 1984 and 1987 but that was eroded by HIV/Aids, which constitutes another big challenge in the fight. According to NTP, 70 out of every 100 TB patients are HIV positive.

The WHO recently ranked Malawi as second best in Africa after Rwanda HIV testing rates in TB settings.

In terms of cure rate, Malawi recorded a 74 percent rate in 2005. This rose to 76 percent in 2006. This, however, was 19 percent lower than the cure rate WHO requires.

The NTP director said Malawi’s efforts on TB were also being threatened by the presence of the multi-drug resistant TB (MDR-TB).

He said although there are very low MDR-TB cases in Malawi currently, its scale of devastation could not be ignored.

If the current MDR-TB situation is mismanaged, it could lead to development of the almost incurable extensively drug resistant TB (XDR-TB).

“It takes too long to treat, about 24 months and the drugs are toxic. A patient will have to get an injection every day for six months. And it is like bush fire that could go wild to become XDR-TB,” Salaniponi said.

According to NTP, it takes up to K3 million to treat an MDR-TB patient, a condition that often results from default of ordinary TB treatment.

In response to the emergency status of TB in the country, government last year developed a two-year plan of action for TB.

The plan, motivated by the low detection rates, seeks to bring universal access to TB diagnosis.

Through the plan, NTP will, among other things, expand community response and establish TB corners in all health facilities where people can easily access or demand for TB related services.

The plan will intensify TB detection and screening of high-risk groups like prisoners.

It is reported that between 8 and 10 percent of TB cases in Malawi come out of prisons and that prisoners are 10 to 15 times more susceptible to contract the disease than the outside society.

Source: http://www.dailytimes.bppmw.com/article.asp?ArticleID=9078

TB fatally stalking Southeast Asia's HIV patients

By, Thaindia, April 12, 2008

India, and Thailand along with Myanmar and Nepal have some of the highest rates of tuberculosis (TB)-HIV co-infection in Southeast Asia, says a World Health Organisation (WHO) report. The prevalence rate of TB among people living with HIV has been estimated as 5.2 percent in India, 7.1 percent in Myanmar, 3.1 percent in Nepal and 7.6 percent in Thailand, says the report on tuberculosis in the region.

Patients with their immune systems disabled by HIV/AIDS face a 30 times greater risk than others of contracting TB. And for HIV/AIDS patients in India, that’s bad news because the country has the highest incidence of TB in the world. India is home to over 3.4 million TB patients - about one-fifth of the global figure.

For the WHO, India is part of the Southeast Asia region along with Bhutan, Bangladesh, Indonesia, Myanmar, Thailand, the Maldives, Sri Lanka, Nepal, Timor-Leste and North Korea. The region has 25 percent of the world’s population but accounts for more than one-third of the global burden of TB, the report said.

“TB is the single most life-threatening infection and the leading cause of mortality among people living with HIV infection in the region,” it added.

“The rapidly expanding HIV epidemic in the region is a growing concern. The HIV epidemic has reached a generalised stage in Thailand, Myanmar and in six states in India,” the report pointed out.

The six high-prevalence states in India are Andhra Pradesh, Karnataka, Manipur, Maharashtra, Nagaland and Tamil Nadu. India has 2.5 million plus HIV patients.

The report said during 2006 in 14 states in India, 25,055 HIV infected TB suspects were referred to the Revised National TB Control Programme (RNTCP) services. Of these, 4,829 were diagnosed as HIV infected TB cases.

“The course of the TB/HIV epidemic in Southeast Asia will depend heavily on efforts to prevent and control both TB and HIV, and decisive steps must be taken now to combat the dual epidemics,” the WHO report said.

Of the 38.6 million people estimated to be living with HIV in the world at the end of 2005, more than four million are in Southeast Asia, said the recently released report on tuberculosis in the region.

Source: http://www.thaindian.com/news-snippet/tb-fatally-stalking-southeast-asias-hiv-patients-4729.html

Lethal TB strain now in Namibia

By, Christof Maletsky, Namibian News, April 2, 2008

Health professionals are quietly treating up to 24 confirmed cases of extensively drug-resistant tuberculosis (XDR-TB) - the worst form of TB with seriously limited treatment options and chances of cure - in Namibian hospitals.

Well-placed health sources have confirmed to The Namibian that the extreme form of TB is currently under control, but expressed fears that the country does not have the capacity to deal with a major outbreak of XDR-TB.

The Namibian had been aware of at least one case being treated at Walvis Bay since December, but health sources said this week that the situation was worse than initially thought.

On Friday, Health Minister Dr Richard Kamwi only expressed fears that Namibia was about to record its first cases of XDR-TB.

TB can usually be treated with a course of four standard, or first-line, anti-TB drugs.

However, if the drugs are misused or mismanaged, multi-drug-resistant TB (MDR-TB) develops and later progresses to extensively drug-resistant TB (XDR-TB).

"There are currently 254 cases of multi-drug-resistant TB under treatment throughout the country.

This is a great concern and is a clear indication that it is only a matter of time before we will have extremely drug-resistant cases, known as XDR Tuberculosis, in Namibia," Kamwi said at the World TB Day event staged at Mariental on Friday.

He said experts in the Ministry of Health were busy reviewing all TB cases with drug resistance to verify the extent of the problem.

"Given the large number of cases, we may well find some incurable XDR-TB amongst this group," Kamwi said.

Kamwi confirmed that Namibia was the country with the second highest TB incidence in the world after Swaziland, with 15 244 cases reported last year alone.

The host region of this year's TB Day event, Hardap, had the highest incidence of TB in Namibia last year, reporting a worrying 1 294 cases per 100 000 people, Kamwi said.

The TB situation is exacerbated by the HIV-AIDS epidemic in the country.

"HIV infection is the major known individual risk factor for the development of TB disease.

Last year 8 186 TB patients representing 54 per cent of the total notified patients were tested for HIV and 59 per cent were HIV positive," Kamwi said.

He said the impact of the dual infection of TB with HIV-AIDS was a major cause for concern, in particular as it affected the Namibian workforce.

"We are experiencing a decline in work productivity; this then results in a decrease in household income, which jeopardises health, nutrition, sanitation, safety, education and care in our nation.

The effect of disease burdens on the workforce can essentially stunt the necessary socio-economic growth on our path toward Vision 2030," the Minister warned.

He called on health workers to be proactive, focused, tireless and united in their responses against the two diseases.

"Clearly, if we are to make an impact in the control of TB, and considering the reported MDR-TB and the concern related to the XDR-TB, we need more skilled healthcare workers," Kamwi said, appealing for more donor assistance to scale up the procurement of medicines, strengthening hospital infrastructure and enhancing control in TB wards.

Source: http://www.namibian.com.na/2008/April/national/08F606ADE1.html

Nearly 1000 people die of Tuberculosis in India everyday

By, CNN-IBN, Ginny Narula, March 24, 2008

New Delhi: Nearly a 1000 people die of Tuberculosis in India every day which is more than the number of deaths caused by Malaria, HIV and Hepatitis combined.

Sushil Kumar has been suffering from tuberculosis and has come all the way from Jharkhand to Delhi to get himself treated.

“I had a bad cough, doctors asked me to go in for a sputum test and I was diagnosed with tuberculosis,” says Kumar.

While incidence of TB has dropped in countries like the US, the increase in drug resistant strains is a huge cause of worry for doctors, especially in countries in Asia and Africa, where 83 per cent of the world's cases of tuberculosis are reported.

Another trend that has doctors worried is that TB is no longer a poor man's disease. Affluent urban India is adding to the number of deaths caused by Tuberculosis.

Even though there has been a decline in numbers. India continues to have the highest number of TB cases followed by China, Indonesia, South Africa and Nigeria.

According to WHO report 2007, in India the death rates due to TB have declined from 42 per 100,000 population in 1990 to 29 per 100,000 population in 2005.

However, the rate of detection of new cases has fallen to 3 per cent from an average of 6 per cent in the preceding five years. This is despite India boasting of the biggest TB detection programme in the world.

Initially these DOT centers were very active however, with time they are not that pro-active due to which there is a decline in rate of detection.

These statistics are worrisome as the higher the cases of early detection, the lower the chance of transmission of the disease and gives a better chance to cure.

Source: http://www.ibnlive.com/news/nearly-1000-people-die-of-tuberculosis-in-india-everyday/61843-17.html

1/5th of drug resistant TB patients live in India

By, Howrah News Service, March 24, 2008

Nearly one-fifth of the world’s TB patients, who have acquired multi drug resistant tuberculosis, are in India.

Presenting a bleak picture of the country’s national TB control programme, the latest World Health Organisation (WHO) report released on Monday has warned that ‘’rising multi drug resistant TB’’ could ‘’ruin’’ India’s efforts to control tuberculosis.

According to the report, India and China record the highest number of TB cases globally. The other high-burden countries are Bangladesh, Indonesia, Burma and Thailand.

Out of the 22 countries that record TB globally, these five countries together have over two million cases or 95 per cent of all cases globally, the report has said.

Commenting on India’s performance in the fight against TB, the report said, "The data for the cohort of infectious TB patients completing their treatments in 2006 for the first time or repeating it after previous failures or defaults shows less than optimal results."

It said that defaults and treatment failures, both among first time treatment seekers and among re-treatment cases raises the probability of multi drug resistance.

"Achieving universal coverage of treatment services is not enough; it needs to be matched by consistent, universally accepted standards of treatment outcomes," said the report.

India has continued to report high morbidity and mortality due to tuberculosis and as many as 1.39 million cases were reported in 2006, said the report on tuberculosis in the South East Asia region.

In 2005, more than 3.2 lakh deaths were reported due to tuberculosis in the country, it said.

The region, with 4.97 million TB cases, carries over one-third of the global burden of TB, said the report. It was revealed that most cases occur in the age group of 15-54 years.

Source: http://howrah.org/india_news/7917.html